Theramex

Acquired

A dedicated women's health company

Luxembourg, Luxembourg · Founded 2018 · $703.0M raised

Headquarters
Luxembourg
Employees
201–500
Founded
2018
Business Model
B2B2C
Total Funding
$703.0M
Last Round
Private EquityJan 2018
Rounds
1
Acquisition Date
Mar 2022

About

Theramex is a global specialty pharmaceutical company solely committed to supporting the health needs of women across key areas of women's health, including contraception, fertility, menopause, and osteoporosis. Founded in 2018 following a divestiture from Teva Pharmaceuticals, Theramex operates in over 80 countries with more than 20 products, serving over 6 million patients. The company works closely with partners, healthcare professionals, and patients to provide women with effective solutions at every stage of their lives. Owned by a consortium of Carlyle and PAI Partners since 2022, Theramex is headquartered in London with significant operations across Europe, Brazil, and beyond.

Summary

Theramex is a Healthcare company based in Luxembourg, Luxembourg, founded in 2018. It has raised $703.0M in total across 1 round, most recently a Private Equity round in Jan 2018. Investors include CVC Capital Partners, The Carlyle Group and PAI Partners.

Tech & App Stack

2 technologies & apps tracked

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Sign up to view the funding chart

Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.

Funding History

AcquisitionMar 2022
$1.4B

Sign up to see all 2 rounds

Full funding history, per-round amounts, and investor participation.

Investors

Similar Companies